Trimethylammonium

Trimethylammonium

SCHEMBL25249359

CCCCCCCCCCCCCCCCC=CCCCCl.CN(C)C

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
TSHR P16473 1/20 0.52
FAAH O00519 5/20 0.52
TRPV1 Q8NER1 1/20 0.52
TERT O14746 3/20 0.45
PTPN1 P18031 3/20 0.45
PPARG P37231 3/20 0.45
PPARD Q03181 3/20 0.45
PPARA Q07869 3/20 0.45
CYP1A2 P05177 2/20 0.45
MAPT P10636 2/20 0.45
CYP2C19 P33261 2/20 0.45
BLM P54132 2/20 0.45
HSD17B10 Q99714 2/20 0.45
FABP4 P15090 2/20 0.45
KMT2A Q03164 2/20 0.45
TOP1 P11387 2/20 0.45
GMNN O75496 1/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL15065665 0.95 ALDH1A1 (0.59) ALDH1A1TSHRFAAHTRPV1TERT
Trimethylammonium SCHEMBL8885847 0.95 ALDH1A1 (0.59) ALDH1A1TSHRFAAHTRPV1TERT
SCHEMBL8846630 0.93 TSHR (0.60) ALDH1A1TSHRFAAHTRPV1TERT
SCHEMBL7135730 0.93 TSHR (0.60) ALDH1A1TSHRFAAHTRPV1TERT
SCHEMBL8846689 0.93 TSHR (0.60) ALDH1A1TSHRFAAHTRPV1TERT
SCHEMBL8846635 0.93 TSHR (0.60) ALDH1A1TSHRFAAHTRPV1TERT
SCHEMBL7135733 0.93 TSHR (0.60) ALDH1A1TSHRFAAHTRPV1TERT
SCHEMBL27216020 0.93 TSHR (0.60) ALDH1A1TSHRFAAHTRPV1TERT
SCHEMBL8436726 0.91 TSHR (0.55) ALDH1A1TSHRFAAHTRPV1TERT
SCHEMBL11122470 0.91 TSHR (0.55) ALDH1A1TSHRFAAHTRPV1TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023186757-A1 FORMULATIONS COMPOSED OF CATIONIC LIPIDS AND POLY(LACTIC-CO-GLYCOLIC ACID) FOR THE DELIVERY OF POLYNUCLEOTIDES INTO CELLS EVONIK OPERATIONS GMBH (DE) 2023-10-05 WO claimed
WO-2023122079-A1 BIOABSORBABLE PARTICLES AND METHOD OF USE W. L. GORE & ASSOCIATES, INC. (US) 2023-06-29 WO disclosed